Structure |
Chemical Name |
CAS |
MF |
|
2,4,6,8-Tetrahydroxy-Pyrimido-(5,4D)Pyrimidine |
6713-54-8 |
C6H4N4O4 |
|
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
|
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
|
5-Pyrimidinecarboxylic acid, 2-chloro-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847463-39-1 |
C17H16ClN3O2 |
|
cytidylyl(5'->3')adenosine |
4833-63-0 |
C19H25N8O11P |
|
6-Chloro-2-mercaptobenzothiazole |
51618-29-2 |
C7H4ClNS2 |
|
2,3-dihydroxypropyl 4-hydroxybenzoate |
93778-15-5 |
C10H12O5 |
|
Pyrazolo[1,5-a]pyridine |
274-56-6 |
C7H6N2 |
|
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
|
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
|
Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate |
139481-41-7 |
C26H23N3O3 |
|
(S)-2-Phenylpyrrolidine |
59347-91-0 |
C10H13N |
|
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2300966-23-6 |
C16H14ClFN4O2 |
|
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
Pyrimidine, 2-chloro-4-(4-chlorophenoxy)-5-fluoro- |
1503263-51-1 |
C10H5Cl2FN2O |
|
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
|
5-BROMO-3-CHLORO-2-METHYLPYRIDINE |
914358-72-8 |
C6H5BrClN |
|
4-(3-Chlorophenyl)-2-(4-nitrophenoxy)-1,3,2-dioxaphosphinane 2-oxide |
883989-27-3 |
C15H13ClNO6P |
|
6-BROMO-1H-INDAZOLE-3-CARBALDEHYDE |
885271-72-7 |
C8H5BrN2O |
|
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
|
4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline |
99010-64-7 |
C14H14ClN3 |
|
Danshen injection intermediate |
|
|
|
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
|
(1R-cis)-3-(phenylmethyl)-4-Thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one |
34103-69-0 |
C11H10N2OS |
|
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
|
Roxadustat Impurity |
1959587-35-9 |
C20H17NO6 |
|
Benzonitrile, 3-(2-amino-6-chloro-4-pyrimidinyl)-2-methyl- |
2239278-05-6 |
C12H9ClN4 |
|
Inosine API manufacturers |
|
|
|
3’-deoxyinosine |
|
|
|
(S)-2-(2,2,2-trifluoroethyl)piperazine dihydrochloride |
|
|
|
Acetoxy Ceftazidime Intermediate |
|
|
|
Flomoxef Intermediate FXMT |
|
|
|
2-Morpholino-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid |
933686-76-1 |
C9H11N3O4 |
|
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
|
1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHYL ESTER |
849067-96-5 |
C9H8N2O2 |
|
Pyrazole |
288-13-1 |
C3H4N2 |
|
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
|
7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
1599440-07-9 |
C27H26N2O6 |
|
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
|
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
|
DIMETHYL PYRAZINE-2,5-DICARBOXYLATE |
13051-89-3 |
C8H8N2O4 |
|
4-Pyrimidinecarboxylic acid |
31462-59-6 |
C5H4N2O2 |
|
(3R,4R,5R)-Oseltamivir |
|
|
|
1,3,5-Triazine, 2-(8-chloro-3-dibenzofuranyl)-4,6-diphenyl- |
2361279-84-5 |
C27H16ClN3O |
|
2-Bromo-3',4'-(methylenedioxy)propiophenone |
52190-28-0 |
C10H9BrO3 |
|
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
|
2,4-DICHLORO-5-METHYL-PHENYLAMINE |
17601-75-1 |
C7H7Cl2N |
|
2-(5-Chloro-[1,1'-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2750016-14-7 |
C18H20BClO2 |
|
1,4-Diazepan-5-one hydrochloride |
208245-76-5 |
C5H11ClN2O |
|
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
|
11-Prostaglandin F2a |
|
|
|
Piperazine, 1-(cyclobutylmethyl)- (9CI) |
82534-54-1 |
C9H18N2 |
|
N-desethyl Etonitazene |
2732926-26-8 |
C20H24N4O3 |
|
4-Formyl-2-isopropylthiazole |
133047-46-8 |
C7H9NOS |
|
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
|
Octenyl succinic anhydride |
26680-54-6 |
C12H18O3 |
|
1-CHLORO-3,3,3-TRIFLUOROACETONE |
431-37-8 |
C3H2ClF3O |
|
(R)-1-benzyl-5-methyl-1,4-diazepane |
1620097-06-4 |
C13H20N2 |
|
ETHYL 2-[3-FLUORO-(TRIFLUOROMETHYL)PHENYL]-4-METHYL-THIAZOLE-5-CARBOXYLATE |
317319-21-4 |
C14H11F4NO2S |
|
4,6-Dichloro-2-isobutylpyrimidine |
1164116-18-0 |
C8H10Cl2N2 |
|
Br-PEG1-NHBoc |
164332-88-1 |
C9H18BrNO3 |
|
3-Bromo-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid |
1823918-84-8 |
C8H5BrN2O2 |
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
|
Methyl 2-(hydroxymethyl)nicotinate |
1697289-97-6 |
C8H9NO3 |
|
Benzenemethanol, 4-cyclohexyl-3-(trifluoromethyl)- |
957205-23-1 |
C14H17F3O |
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid |
1616342-45-0 |
C15H16N2O6 |
|
5-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE |
485841-48-3 |
C8H5FN2O |
|
4-Fluoro-5-isoquinolinesulfonyl chloride hydrochloride (1:1) |
906820-08-4 |
C9H5Cl3FNO2S |
|
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
|
(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL |
849067-97-6 |
C8H8N2O |
|
(1H-BENZO[D]IMIDAZOL-2-YL)METHANAMINE |
5805-57-2 |
C8H9N3 |
|
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
|
DMAC-BP |
1685287-55-1 |
C43H36N2O |
|
tert-butyl endo-3-hydroxy-9-azabicyclo[3.3.1]nonane-9-carboxylate |
934180-37-7 |
C13H23NO3 |
|
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
|
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
|
Cefdinir Impurity E (CP) |
|
|
|
Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate |
96287-41-1 |
C17H14O8 |
|
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
|
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
1370250-39-7 |
C17H17N3O4 |
|
(S)-4-((9H-fluoren-9-yl)methyl) 3-methyl 2H-1,4-oxazine-3,4(3H)-dicarboxylate |
942152-97-8 |
C21H19NO5 |
|
3-Cyano-1,2,4-triazole |
3641-10-9 |
C3H2N4 |
|
1-Hydroxyethylethoxypiperazine |
13349-82-1 |
C8H18N2O2 |
|
1-BENZYLOXYCARBONYLPIPERIDINE-3-CARBONYL CHLORIDE |
216502-94-2 |
C14H16ClNO3 |
|
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
|
4-Bromomethypiperidine-1-carboxylic acid tert-butyl ester |
158407-04-6 |
C11H20BrNO2 |
|
7-Hydroxyquinolinone |
70500-72-0 |
C9H7NO2 |
|
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
|
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
|
ethyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-carboxylate |
1418754-60-5 |
C21H29BO4 |
|
BMK Glycidic Acid (sodium salt) |
5449-12-7 |
C10H11NaO3 |
|
Dibenzofuran, 3-bromo-6-phenyl- |
2181786-99-0 |
C18H11BrO |
|
4,6-dichloro-2-cyclobutylpyrimidine |
1353856-95-7 |
C8H8Cl2N2 |
|
Azacitidine Isomer |
|
|
|
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
|
Cefazolin Related Compound D |
|
|
|
Sugammadex sodium hexabromide intermediate |
|
|
|
(3S,5R,2R,3S)-posaconazole |
|
|
|
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
|
2 6-BIS[(4S 5S)-4-METHYL-5-PHENYL-2-OXA& |
185346-20-7 |
C25H23N3O2 |